Intersect ENT (XENT): Positive Management Meetings Support Overweight Rating - Piper Jaffray
Tweet Send to a Friend
Piper Jaffray analyst, Matt O'Brien, reiterated his Overweight rating on share of Intersect ENT (NASDAQ: XENT) after meeting with CFO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
